Ra. Neves et al., HERPES-ZOSTER PERIPHERAL ULCERATIVE KERATITIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Cornea, 15(5), 1996, pp. 446-450
The purpose of this study was to describe the clinical characteristics
and course of peripheral ulcerative keratitis (PUK) secondary to herp
es varicella-zoster virus in patients with the acquired immunodeficien
cy syndrome (AIDS). Three AIDS patients with ocular herpes tester infe
ction (mean age at onset, 33.0 years; range, 30-42) developed PUK. The
three patients had skin involvement, and two of them had bilateral ke
ratouveitis. All were treated with high-dose oral acyclovir (4 g/day)
with or without topical antiviral therapy, Two of the patients respond
ed well to oral acyclovir, but one of them stopped the treatment, and
bilateral progressive outer retinal necrosis and lethal encephalitis d
eveloped. The third patient had a recurrent. episode of inflammation w
ith PUK, extensive stromal scarring, and deep neovascularization. AIDS
patients with herpes varicella-zoster virus infection may have severe
and protracted corneal manifestations, including PUK. The correct dia
gnosis and aggressive early long-term systemic antiviral treatment mus
t be instituted to control inflammation, ulcer progression, and compli
cations.